Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.
about
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@en
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@nl
type
label
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@en
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@nl
prefLabel
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@en
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@nl
P2093
P2860
P1433
P1476
Phase II Trial Using a Combina ...... osed Resectable Rectal Cancer.
@en
P2093
Ashwani Rajput
Ben J Liem
Cristina Murray-Krezan
Emilio P Araujo-Mino
Fa Chyi Lee
Glenory Heywood
Joshua A Hanson
M Houman Fekrazad
Yehuda Z Patt
P2860
P356
10.1634/THEONCOLOGIST.2017-0474
P577
2017-11-20T00:00:00Z